Latest Insider Transactions at Ampio Pharmaceuticals, Inc. (AMPE)
This section provides a real-time view of insider transactions for Ampio Pharmaceuticals, Inc. (AMPE). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Ampio Pharmaceuticals, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Ampio Pharmaceuticals, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 09
2023
|
J Kevin Buchi Director |
BUY
Open market or private purchase
|
Direct |
21,858
+12.96%
|
$0
$0.29 P/Share
|
|
Jun 08
2023
|
J Kevin Buchi Director |
BUY
Open market or private purchase
|
Direct |
25,000
+16.67%
|
$0
$0.3 P/Share
|
|
May 24
2023
|
Michael A Martino CEO |
BUY
Open market or private purchase
|
Direct |
76,890
+50.0%
|
$0
$0.29 P/Share
|
|
May 16
2023
|
J Kevin Buchi Director |
BUY
Open market or private purchase
|
Direct |
32,534
+24.55%
|
$0
$0.27 P/Share
|
|
May 15
2023
|
J Kevin Buchi Director |
BUY
Open market or private purchase
|
Direct |
44,026
+39.49%
|
$0
$0.25 P/Share
|
|
May 12
2023
|
J Kevin Buchi Director |
BUY
Open market or private purchase
|
Direct |
23,440
+50.0%
|
$0
$0.24 P/Share
|
|
May 12
2023
|
David R Stevens Director |
BUY
Open market or private purchase
|
Direct |
45,000
+30.21%
|
$0
$0.22 P/Share
|
|
May 11
2023
|
David R Stevens Director |
BUY
Open market or private purchase
|
Direct |
50,000
+36.08%
|
$0
$0.22 P/Share
|
|
Jan 01
2022
|
Michael Macaluso |
SELL
Payment of exercise price or tax liability
|
Direct |
68,400
-2.54%
|
$0
$0.57 P/Share
|
|
Jan 01
2022
|
Holli Cherevka PRESIDENT AND COO |
SELL
Payment of exercise price or tax liability
|
Direct |
47,200
-10.31%
|
$0
$0.57 P/Share
|
|
Jan 01
2022
|
Dan Stokely CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
22,914
-6.84%
|
$0
$0.57 P/Share
|
|
Oct 27
2021
|
Michael Macaluso |
SELL
Payment of exercise price or tax liability
|
Direct |
43,470
-1.59%
|
$43,470
$1.64 P/Share
|
|
Oct 27
2021
|
Holli Cherevka PRESIDENT AND COO |
SELL
Payment of exercise price or tax liability
|
Direct |
41,980
-8.4%
|
$41,980
$1.64 P/Share
|
|
Oct 27
2021
|
Dan Stokely CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
28,127
-7.74%
|
$28,127
$1.64 P/Share
|
|
Oct 11
2021
|
Holli Cherevka PRESIDENT AND COO |
BUY
Grant, award, or other acquisition
|
Direct |
500,000
+50.0%
|
-
|
|
Oct 11
2021
|
Dan Stokely CFO |
BUY
Grant, award, or other acquisition
|
Direct |
335,000
+47.97%
|
-
|
|
Oct 11
2021
|
Michael Macaluso |
BUY
Grant, award, or other acquisition
|
Direct |
950,000
+25.77%
|
-
|
|
Jun 25
2021
|
Dan Stokely CFO |
SELL
Open market or private sale
|
Direct |
22,500
-44.28%
|
$22,500
$1.79 P/Share
|
|
Jun 25
2021
|
Dan Stokely CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
22,500
+30.69%
|
$0
$0.43 P/Share
|
|
May 21
2021
|
Philip H Coelho |
SELL
Open market or private sale
|
Direct |
6,737
-3.2%
|
$13,474
$2.0 P/Share
|
|
May 21
2021
|
Philip H Coelho |
BUY
Exercise of conversion of derivative security
|
Direct |
6,737
+3.11%
|
$0
$0.4 P/Share
|
|
May 21
2021
|
Holli Cherevka PRESIDENT AND COO |
SELL
Open market or private sale
|
Direct |
2,603
-100.0%
|
$5,206
$2.0 P/Share
|
|
May 21
2021
|
Holli Cherevka PRESIDENT AND COO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,603
+50.0%
|
$0
$0.51 P/Share
|
|
May 18
2021
|
Dan Stokely CFO |
SELL
Open market or private sale
|
Direct |
35,000
-55.28%
|
$35,000
$1.83 P/Share
|
|
May 17
2021
|
Dan Stokely CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
35,000
+35.6%
|
$0
$0.43 P/Share
|
|
Apr 29
2021
|
Philip H Coelho |
SELL
Open market or private sale
|
Direct |
3,263
-1.58%
|
$6,526
$2.0 P/Share
|
|
Apr 29
2021
|
Philip H Coelho |
BUY
Exercise of conversion of derivative security
|
Direct |
3,263
+1.55%
|
$0
$0.4 P/Share
|
|
Apr 27
2021
|
Holli Cherevka PRESIDENT AND COO |
SELL
Open market or private sale
|
Direct |
74,631
-100.0%
|
$149,262
$2.0 P/Share
|
|
Apr 27
2021
|
Holli Cherevka PRESIDENT AND COO |
BUY
Exercise of conversion of derivative security
|
Direct |
74,631
+43.71%
|
$0
$0.51 P/Share
|
|
Apr 27
2021
|
Philip H Coelho |
SELL
Open market or private sale
|
Direct |
20,000
-8.95%
|
$40,000
$2.0 P/Share
|
|
Apr 27
2021
|
Philip H Coelho |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+8.21%
|
$0
$0.4 P/Share
|
|
Mar 16
2021
|
Dan Stokely CFO |
SELL
Open market or private sale
|
Direct |
40,000
-58.55%
|
$40,000
$1.83 P/Share
|
|
Mar 16
2021
|
Dan Stokely CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
40,000
+36.93%
|
$0
$0.43 P/Share
|
|
Feb 12
2021
|
Dan Stokely CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
24,185
-46.07%
|
$48,370
$2.55 P/Share
|
|
Feb 12
2021
|
Dan Stokely CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
52,500
+33.33%
|
$105,000
$2.55 P/Share
|
|
Jan 04
2021
|
David R Stevens Director |
BUY
Grant, award, or other acquisition
|
Direct |
13,513
+9.13%
|
$13,513
$1.48 P/Share
|
|
Jan 04
2021
|
Philip H Coelho |
BUY
Grant, award, or other acquisition
|
Direct |
13,513
+6.23%
|
$13,513
$1.48 P/Share
|
|
Jan 04
2021
|
Richard B Giles |
BUY
Grant, award, or other acquisition
|
Direct |
13,513
+4.12%
|
$13,513
$1.48 P/Share
|
|
Jan 04
2021
|
David Bar Or |
BUY
Grant, award, or other acquisition
|
Direct |
13,513
+12.71%
|
$13,513
$1.48 P/Share
|